Helsinki

Helsinki has established itself as a world-class life sciences ecosystem driven by the seamless integration of academic research and healthcare innovation.

The city is globally recognized for its leadership in precision medicine and digital health, fueled by the Helsinki Institute of Life Science (HiLIFE) and the world-renowned Institute for Molecular Medicine Finland (FIMM).

Leveraging the unique Finnish biobank data and a national digital health data space, the region offers unparalleled opportunities for pharmaceutical development and genomic research.

Helsinki’s thriving biotechnology sector excels in converting fundamental bioscience into scalable biotech startups through specialized hubs like the Viikki and Meilahti campuses.

In the medical device and healthtech arena, the city facilitates rapid clinical trials and R&D collaboration within the HUS Helsinki University Hospital, one of Europe’s largest healthcare providers.

The ecosystem is further strengthened by Health Capital Helsinki, a dedicated alliance that bridges the gap between public-private partnerships and global investors.

This collaborative environment supports the entire value chain, from early-stage drug discovery to advanced AI-driven diagnostics.

With a deep pool of STEM talent and cutting-edge research infrastructures, Helsinki is a primary destination for international companies seeking a stable, data-rich environment for life science investment.

Today, the city stands at the forefront of the European Health Data Space (EHDS), defining the future of personalized patient care and sustainable healthcare solutions.